The Cartagena Protocol on Biosafety

Frequently Asked Questions

All Questions


The Secretariat has prepared these questions and answers to assist public understanding of the Cartagena Protocol on Biosafety. It is not intended to provide legal interpretation of the Protocol. Please refer to the original text of the Protocol for any further information.

a. Biosafety and Biotechnology
(Questions 1-7)

b. The Biosafety Protocol and its Implementation
(Questions 8-28)

c. Becoming a Party to the Protocol
(Questions 29-35)

10. What is the "precautionary approach"? How is it reflected in the Protocol?

One of the outcomes of the United Nations Conference on Environment and Development (also known as the Earth Summit) held in Rio de Janeiro, Brazil, in June 1992, was the adoption of the Rio Declaration on Environment and Development, which contains 27 principles to underpin sustainable development. One of these principles is Principle 15 which states that "In order to protect the environment, the precautionary approach shall be widely applied by States according to their capabilities. Where there are threats of serious or irreversible damage, lack of full scientific certainty shall not be used as a reason for postponing cost-effective measures to prevent environmental degradation."


Elements of the precautionary approach find reflection in a number of the provisions of the Protocol, such as:


  • The preamble, reaffirming "the precautionary approach contained in Principle 15 of the Rio Declaration on environment and Development; ".
  • Article 1, indicating that the objective of the Protocol is "in accordance with the precautionary approach contained in Principle 15 of the Rio Declaration on environment and Development";
  • Article 10.6 and 11.8, stating:
    "Lack of scientific certainty due to insufficient relevant scientific information and knowledge regarding the extent of the potential adverse effects of an LMO on biodiversity, taking into account risks to human health, shall not prevent a Party of import from taking a decision, as appropriate, with regard to the import of the LMO in question, in order to avoid or minimize such potential adverse effects."
  • Annex III on risk assessment, stating:
    "Lack of scientific knowledge or scientific consensus should not necessarily be interpreted as indicating a particular level of risk, an absence of risk, or an acceptable risk."